moxifloxacin has been researched along with balofloxacin in 4 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (balofloxacin) | Trials (balofloxacin) | Recent Studies (post-2010) (balofloxacin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 54 | 5 | 20 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, Y; Feng, LS; Guo, HY; Hao, XQ; Liu, ML; Meng, S; Wang, B | 1 |
| Brady, SF; Koirala, B; Peek, J | 1 |
| Chen, D; Prahalad, AK; Rosen, JE; Schluter, G; Spratt, TE; Williams, GM | 1 |
| Betanzos-Cabrera, G; Cancino-Díaz, JC; Cancino-Díaz, ME; González-González, G; Juárez-Verdayes, MA | 1 |
4 other study(ies) available for moxifloxacin and balofloxacin
| Article | Year |
|---|---|
Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Drug Design; Fluoroquinolones; Hydrophobic and Hydrophilic Interactions; Isatin; Microbial Sensitivity Tests; Vero Cells | 2010 |
Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; HEK293 Cells; Humans; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus | 2022 |
A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Aza Compounds; Cell Line; Deoxyguanosine; Epithelium; Fluoroquinolones; Liver; Moxifloxacin; Quinolines; Quinolones; Rats; Ultraviolet Rays | 1997 |
Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.
Topics: Anti-Infective Agents; Aza Compounds; Conjunctivitis; Corneal Ulcer; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus epidermidis | 2009 |